BVT-23202-04467
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 815 / CO
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2021-01-01
-
2021-01-04
Dose 2 — Pfizer-BioNTech
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-09
- 2021-01-16
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-04-07
- 2021-07-05
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
-
2022-02-04
Survey response — 3 months, dose 3MedDRA: Cough, Headache — Feeling: Good · Be unable to work or attend schoolFree text: Minimal symptoms. Headache, mild coughMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Survey response — 6 months, dose 3MedDRA: Adverse drug reaction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: UTI Allergic reaction, rash, to most likely a medicationMedDRA releases: 2024-11 · check-in free text available
-
2022-05-06
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-09
-
2022-05-10
Call successfulDoes not wish to fill out VAERS report
- 2022-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 3 months, dose 3
Symptoms: Minimal symptoms. Headache, mild cough
Release 11 — 6 months, dose 3
Symptoms: UTI Allergic reaction, rash, to most likely a medication
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release